IQVIA Holdings | IQV - Cost Of Sales


IQVIA Holdings reported $3.08B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Accenture USD 12.58B 896K Mar/2026
Agilent USD 845M 7M Mar/2026
Bruker USD 443.6M 84.4M Mar/2026
Cardinal Health USD 58.54B 4.82B Mar/2026
Celltrion KRW 107.42B 295.44B Dec/2025
Charles River Laboratories USD 716.51M 5.76M Mar/2026
Cigna USD 62.41B 4.1B Mar/2026
Cognizant Technology Solutions USD 3.78B 105M Mar/2026
Computer Programs Systems USD 52.17M 9.8M Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
CVS Health USD 84.8B 7.32B Mar/2026
Danaher USD 2.36B 512M Mar/2026
Dentsply International USD 453M 65M Mar/2026
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Divis Laboratories Ltd INR 12.39B 1.76B Mar/2026
Elevance Health USD 38.07B 75M Dec/2025
Humana USD 26.54B 1.15B Mar/2025
IBM USD 7.76B 787M Dec/2025
Illumina USD 370M 30M Mar/2026
Infosys INR 326.17B 322.65B Dec/2025
Kangmei Pharma CNY 841.45M 271.27M Mar/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Laboratory Of America USD 2.6B 4.2M Mar/2026
McKesson USD 92.25B 10.22B Mar/2026
Mettler Toledo International USD 410.92M 63.05M Mar/2026
Organigram Holdings CAD 56.93M 20.53M Dec/2025
Pharma Mar EUR 3.66M 116K Mar/2026
Qiagen NV USD 217.43M 29.65M Dec/2025
Quest Diagnostics USD 1.99B 57M Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Sartorius EUR 484.6M 46.6M Mar/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Thermo Fisher Scientific USD 6.96B 620M Mar/2026
Tilray USD 164.37M 8.41M Sep/2025
UnitedHealth USD 94.72B 2.2B Dec/2025
Veeva Systems USD 220.92M 7.45M Mar/2026
Veradigm USD 124.74M 56.25M Dec/2022
Waters USD 725M 350.06M Mar/2026
Zealand Pharma A/S 410K 5K Jun/2025
Zz Pientze Pharmaceu CNY 1.58B 245.15M Mar/2026